Clinical study reveals bmiSMART I-CONTROL appetite reducer magnifies weight loss

Proprietary ingredient clinically shown to increase satiety and support significant weight loss in overweight and obese adults

InQpharm NA, the company that brought plant-based, weight-loss system bmiSMART to the US, has announced the publication of a double-blind, placebo-controlled 14-week study in Advancement in Medicinal Plant Research, revealing significant benefits of appetite reduction on weight loss.

The study evaluated the effectiveness and tolerability of Redusure (IQP-AK-102), a patent-pending fibre complex and key ingredient in bmiSMART's I-CONTROL appetite reducer, for promoting weight loss in overweight and obese individuals. Results found that subjects who received Redusure saw significantly higher weight reduction than those who received the placebo.

'This research confirms Redusure's role in appetite reduction by promoting pleasant feelings of fullness when taken before meals,' stated Holly Tully, VP of Marketing, InQpharm NA. 'The study also reveals just how effective these appetite-reducing properties are in helping individuals lose weight at a consistent, healthy rate.'

Companies